期刊
NUTRIENTS
卷 13, 期 10, 页码 -出版社
MDPI
DOI: 10.3390/nu13103522
关键词
pancreatic cancer; cachexia; malnutrition; survival; sarcopenic obesity; PEI; sarcopenia; nutritional status; QoL; multidisciplinary board
Pancreatic cancer patients often experience malnutrition, leading to cancer cachexia and sarcopenic obesity which significantly impact the prognosis of the disease. However, the importance of these nutritional imbalances is often overlooked in clinical practice, with detrimental effects on patient outcomes.
Pancreatic cancer represents a very challenging disease, with an increasing incidence and an extremely poor prognosis. Peculiar features of this tumor entity are represented by pancreatic exocrine insufficiency and an early and intense nutritional imbalance, leading to the highly prevalent and multifactorial syndrome known as cancer cachexia. Recently, also the concept of sarcopenic obesity has emerged, making the concept of pancreatic cancer malnutrition even more multifaceted and complex. Overall, these nutritional derangements play a pivotal role in contributing to the dismal course of this malignancy. However, their relevance is often underrated and their assessment is rarely applied in clinical daily practice with relevant negative impact for patients' outcome in neoadjuvant, surgical, and metastatic settings. The proper detection and management of pancreatic cancer-related malnutrition syndromes are of primary importance and deserve a specific and multidisciplinary (clinical nutrition, oncology, etc.) approach to improve survival, but also the quality of life. In this context, the introduction of a Nutritional Oncology Board in routine daily practice, aimed at assessing an early systematic screening of patients and at implementing nutritional support from the time of disease diagnosis onward seems to be the right path to take.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据